Dermatitis Herpetiformis

by Dr. S.N. Gupta

Dermatitis herpetiformis (DH) is a chronic, intensely itchy autoimmune blistering rash that represents the cutaneous (skin) manifestation of celiac disease. It is triggered by ingestion of gluten—a protein found in wheat, barley, and rye—in genetically predisposed individuals, leading to characteristic IgA antibody deposits in the skin and a distinctive papulovesicular eruption.

What Is Dermatitis Herpetiformis?

Dermatitis herpetiformis is not a simple allergy or contact dermatitis; it is an autoimmune condition tightly linked to gluten-sensitive enteropathy (celiac disease). Although many patients with DH do not report obvious gastrointestinal symptoms, nearly all have some degree of gluten-driven intestinal involvement, even if subclinical.

The hallmark of DH is its pathophysiology: ingestion of gluten leads to production of IgA antibodies against epidermal transglutaminase (eTG), which then deposit in the dermal papillae of the skin, triggering inflammation, microabscesses, and the classic itchy rash.

Epidemiology and Who Gets DH?

DH is relatively uncommon but well-documented worldwide. Key epidemiological features include:

• Prevalence: DH occurs in approximately 10–20% of patients with celiac disease.
• Sex distribution: Males are affected about twice as often as females (male:female ratio ~2:1).
• Age of onset: Most cases present between ages 30–40, though it can occur at any age.
• Genetic predisposition: Over 90% of patients carry HLA-DQ2, and about 5% carry HLA-DQ8, the same genetic markers strongly associated with celiac disease.

Clinical Features: Recognizing the Rash

The rash of dermatitis herpetiformis is distinctive and often unmistakable once you know what to look for.

Typical Presentation

• Intense itching: Pruritus (itching) is often severe and may precede visible lesions.
• Symmetrical distribution: Lesions typically appear on extensor surfaces—elbows, knees, buttocks, shoulders, scalp, and back—in a symmetrical pattern.
• Morphology: Small, grouped papules and vesicles (blisters) that may crust or erode due to scratching.
• Chronic course: Without treatment, the rash tends to persist or recur over months to years.

Because patients often scratch vigorously, intact blisters may be rare at presentation; instead, excoriated papules, crusts, and post-inflammatory hyperpigmentation are common.

Pathophysiology: Why Does Gluten Cause a Skin Rash?

Understanding the mechanism helps explain why DH is inseparable from celiac disease.

• Gluten ingestion: In genetically susceptible individuals, gluten peptides trigger an immune response.
• Antibody formation: The immune system produces IgA antibodies against epidermal transglutaminase (eTG), an enzyme in the skin.
• Immune complex deposition: These IgA–eTG complexes deposit in the dermal papillae.
• Inflammatory cascade: Complement activation and neutrophil recruitment lead to microabscess formation, blistering, and intense itching.

Importantly, the same gluten-driven process also affects the small intestine, causing the villous atrophy characteristic of celiac disease—even if gastrointestinal symptoms are mild or absent.

Diagnosis: Confirming DH

Accurate diagnosis is critical because treatment is lifelong and has major dietary implications. Diagnosis typically involves a combination of clinical assessment, serology, and skin biopsy.

1. Clinical Suspicion

A symmetrical, intensely itchy rash on extensor surfaces in an adult should raise suspicion for DH, especially if there is a personal or family history of celiac disease or other autoimmune conditions.

2. Serological Testing

Blood tests can support the diagnosis and evaluate for celiac disease:

• Anti-tissue transglutaminase (anti-tTG) IgA: Often positive in DH, though titers may be lower than in classic celiac disease.
• Anti-endomysial antibodies (EMA): Highly specific for celiac disease and frequently positive in DH.
• Anti-epidermal transglutaminase (anti-eTG) IgA: May be elevated and correlates with skin disease activity.

Note: Serology can be negative in some DH patients, especially if they have already started a gluten-free diet.

3. Skin Biopsy with Direct Immunofluorescence (DIF)

This is the gold standard for diagnosing DH.

• Procedure: A small skin biopsy is taken from perilesional (near the lesion) normal-appearing skin.
• Finding: Granular IgA deposits in the dermal papillae are pathognomonic (diagnostic) for DH.

Importantly, patients should not start a gluten-free diet before biopsy, as this can reduce IgA deposits and lead to false-negative results.

4. Intestinal Evaluation

Although not always required for DH diagnosis, many clinicians recommend:

• Upper endoscopy with duodenal biopsy: To assess for celiac enteropathy, especially if serology is positive or symptoms suggest gut involvement.
• Nutritional assessment: Screening for deficiencies (iron, folate, B12, vitamin D, etc.) common in celiac disease.

Treatment: Lifelong Gluten-Free Diet Plus Medication

Treatment of dermatitis herpetiformis has two pillars: a strict, lifelong gluten-free diet (GFD) and pharmacologic therapy for rapid symptom control.

1. Gluten-Free Diet: The Cornerstone of Therapy

A strict gluten-free diet is the only disease-modifying treatment for DH. It addresses both the skin manifestations and the underlying celiac disease, reducing long-term risks such as intestinal lymphoma and other autoimmune complications.

What Does “Gluten-Free” Mean?

Patients must eliminate all sources of:

• Wheat (including spelt, kamut, semolina, durum)
• Barley (including malt, malt vinegar, malt extract)
• Rye

Allowed Foods

• Naturally gluten-free grains: rice, corn, quinoa, millet, buckwheat, amaranth, sorghum.
• Uncontaminated oats (certified gluten-free) are generally permitted.
• Fresh fruits, vegetables, legumes, nuts, seeds, dairy (if tolerated), eggs, meat, fish.

Important Considerations

• Dietitian involvement: Referral to a dietitian experienced in celiac disease and DH is strongly recommended at diagnosis.
• Avoid processed “gluten-free” products: These can be high in sugar, fat, and refined carbohydrates, and may lack fiber and micronutrients.
• Cross-contamination: Even trace gluten can trigger symptoms; careful food preparation and label reading are essential.

The skin typically improves slowly on a GFD—often over months to 1–2 years—so medication is usually needed initially.

2. Dapsone: Rapid Symptom Control

Dapsone is the first-line medication for quickly controlling the rash and itching in DH.

How It Works

Dapsone has anti-inflammatory and neutrophil-inhibiting effects, reducing the skin lesions within days to weeks, long before the gluten-free diet takes full effect.

Dosing

• Typical adult starting dose: 50 mg once daily, adjusted based on response and tolerance.
• Goal: Use the lowest effective dose to control symptoms.

Monitoring and Side Effects

Dapsone requires careful monitoring due to potential adverse effects:

• Hemolysis and methemoglobinemia: Especially in patients with G6PD deficiency; G6PD screening is recommended before starting.
• Agranulocytosis: Rare but serious; periodic blood counts are advised.
• Peripheral neuropathy, liver enzyme elevation, and hypersensitivity reactions may occur.

Duration of Therapy

• Dapsone is typically continued for about 18–24 months while the gluten-free diet takes effect.
• Once skin symptoms are well-controlled on GFD alone, dapsone can be gradually tapered and often discontinued.

3. Alternative or Adjunctive Therapies

In patients who cannot tolerate dapsone or have contraindications, other options include:

• Sulfapyridine or sulfamethoxypyridazine: Alternative sulfonamides with similar efficacy but different side-effect profiles.
• Topical corticosteroids: May provide limited symptomatic relief but do not alter disease course.
• Immunosuppressants (e.g., azathioprine, mycophenolate): Rarely used, reserved for refractory cases under specialist care.

Living with Dermatitis Herpetiformis: Practical Management Tips

Managing DH successfully requires more than medication and diet; it involves lifestyle adjustments and ongoing support.

Nutrition and Supplementation

Because celiac disease (and thus DH) can lead to malabsorption, patients should be screened and treated for:

• Iron deficiency anemia
• Folate and vitamin B12 deficiency
• Vitamin D and calcium deficiency (bone health)
• Zinc, magnesium, and other micronutrients

A balanced gluten-free diet emphasizing whole foods, lean proteins, healthy fats, and fiber-rich vegetables and fruits is ideal.

Skin Care

• Avoid scratching to prevent secondary infection and scarring; cool compresses and emollients may help.
• Use gentle, fragrance-free soaps and moisturizers.
• Wear loose, breathable clothing to reduce friction and irritation.

Psychosocial Support

• DH can significantly impact quality of life due to chronic itching, dietary restrictions, and social limitations.
• Support groups, celiac disease organizations, and mental health resources can be invaluable.

Long-Term Outlook and Complications

With strict adherence to a gluten-free diet, the prognosis for dermatitis herpetiformis is excellent.

• Skin remission: Most patients achieve complete or near-complete clearance of the rash within 1–2 years of strict GFD.
• Medication discontinuation: Dapsone can often be stopped after 18–24 months if the diet is maintained.
• Reduced celiac complications: GFD lowers the risk of intestinal lymphoma, osteoporosis, and other autoimmune diseases associated with untreated celiac disease.

However, lapses in the diet—even small amounts of gluten—can trigger recurrence of the rash and intestinal damage. Lifelong vigilance is essential.

When to See a Specialist

Patients with suspected or confirmed DH should be managed by a multidisciplinary team, including:

• Dermatologist: For diagnosis (biopsy), dapsone management, and skin monitoring.
• Gastroenterologist: For celiac disease evaluation, endoscopy if indicated, and long-term gut health.
• Registered dietitian: For personalized gluten-free diet planning and nutritional optimization.
• Primary care provider: For coordination of care, vaccination updates, and screening for associated conditions (e.g., thyroid disease, type 1 diabetes).

Key Takeaways for Patients and Caregivers

• Dermatitis herpetiformis is the skin manifestation of celiac disease, driven by gluten ingestion in genetically susceptible people.
• The rash is intensely itchy, symmetrical, and typically affects elbows, knees, buttocks, and scalp.
• Diagnosis requires skin biopsy with direct immunofluorescence showing granular IgA deposits; do not start a gluten-free diet before biopsy.
• Treatment combines a strict, lifelong gluten-free diet (the only disease-modifying therapy) with dapsone for rapid symptom control.
• With adherence, most patients achieve remission and can discontinue medication within 1–2 years.
• Ongoing follow-up is crucial to monitor nutritional status, medication side effects, and dietary adherence.